Lake Street Maintains Buy Rating for CVRx: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Lake Street has reaffirmed its Buy rating on CVRx (NASDAQ:CVRX) and increased its price target from $21.00 to $32.00. CVRx's stock is currently trading at $31.44, up 1.29% over the last 24 hours. The new price target suggests a modest 1.78% potential upside. CVRx is a medical device company specializing in neuromodulation solutions for cardiovascular diseases, with its main product, Barostim, targeting the Autonomic Nervous System to treat heart failure.
December 27, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lake Street has maintained a Buy rating on CVRx and raised the price target to $32, indicating a potential upside of 1.78% from the current price of $31.44.
The reaffirmation of a Buy rating and an increased price target by Lake Street is a positive signal to investors, suggesting confidence in CVRx's growth potential. The modest potential upside of 1.78% to the new target price indicates a conservative but positive outlook, which may lead to a slight increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100